Bavarian Nordic aktie (BAVA) | Pressmeddelande - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

•Morgonkollen: Aktuella händelser du bör ha koll på

Pressmeddelanden från Bavarian Nordic

 Bevaka pressreleaser
Kurs från TradingView
StartNyheterPressreleaserRiktkurserInsynshandelBlankningAnalyserBloggarVideosPodcasts

Correction: Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S

Correction: Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S

GlobeNewswire • 09 Apr 18:02

Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S

Resolutions of the Annual General Meeting 2025 of Bavarian Nordic A/S

GlobeNewswire • 09 Apr 17:38

Bavarian Nordic Receives U.S. FDA Approval of Freeze-Dried Smallpox and Mpox Vaccine

Bavarian Nordic Receives U.S. FDA Approval of Freeze-Dried Smallpox and Mpox Vaccine

GlobeNewswire • 31 Mar 22:38

Bavarian Nordic A/S – Notice Convening Annual General Meeting

Bavarian Nordic A/S – Notice Convening Annual General Meeting

GlobeNewswire • 12 Mar 12:00

Bavarian Nordic Announces Acceptance of Marketing Authorization Application for Chikungunya Vaccine in the UK for Persons Aged 12 and Older

Bavarian Nordic Announces Acceptance of Marketing Authorization Application for Chikungunya Vaccine in the UK for Persons Aged 12 and Older

GlobeNewswire • 07 Mar 07:30

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/co...

GlobeNewswire • 05 Mar 08:08

Bavarian Nordic Publishes Annual Report 2024

Bavarian Nordic Publishes Annual Report 2024

GlobeNewswire • 05 Mar 07:50

Bavarian Nordic Receives Marketing Authorization in Europe for Chikungunya Vaccine for Persons Aged 12 and Older

Bavarian Nordic Receives Marketing Authorization in Europe for Chikungunya Vaccine for Persons Aged 12 and Older

GlobeNewswire • 28 Feb 17:14

Bavarian Nordic Partners with Biological E Limited to Expand Global Access to Chikungunya Vaccine

Bavarian Nordic Partners with Biological E Limited to Expand Global Access to Chikungunya Vaccine

GlobeNewswire • 25 Feb 07:00

Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and Older

Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and Older

GlobeNewswire • 14 Feb 23:27

Bavarian Nordic Reports Preliminary 2024 Financial Results in Line with Upgraded Guidance and Guides for 2025

Bavarian Nordic Reports Preliminary 2024 Financial Results in Line with Upgraded Guidance and Guides for 2025

GlobeNewswire • 03 Feb 18:24

Bavarian Nordic – Completion of Share Buy-Back Program

Bavarian Nordic – Completion of Share Buy-Back Program

GlobeNewswire • 31 Jan 20:31

Bavarian Nordic Receives Positive CHMP Opinion for Chikungunya Vaccine for Persons Aged 12 and Older

Bavarian Nordic Receives Positive CHMP Opinion for Chikungunya Vaccine for Persons Aged 12 and Older

GlobeNewswire • 31 Jan 11:50

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

GlobeNewswire • 27 Jan 07:30

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

GlobeNewswire • 20 Jan 07:30

Bavarian Nordic Launches Planned Share Buy-Back Program of DKK 150 Million

Bavarian Nordic Launches Planned Share Buy-Back Program of DKK 150 Million

GlobeNewswire • 09 Jan 08:09

Bavarian Nordic Enters License and Manufacturing Agreement for its Mpox Vaccine with Serum Institute of India

Bavarian Nordic Enters License and Manufacturing Agreement for its Mpox Vaccine with Serum Institute of India

GlobeNewswire • 16 Dec 2024 07:30

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/com...

GlobeNewswire • 13 Dec 2024 17:30

New Incentive Program Established for Members of Executive Management and Selected Employees in Bavarian Nordic

New Incentive Program Established for Members of Executive Management and Selected Employees in Bavarian Nordic

GlobeNewswire • 13 Dec 2024 08:00

Bavarian Nordic to Launch DKK 150 Million Share Buy-back Program

Bavarian Nordic to Launch DKK 150 Million Share Buy-back Program

GlobeNewswire • 11 Dec 2024 08:14

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/com...

GlobeNewswire • 29 Nov 2024 17:30

Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise

Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise

GlobeNewswire • 29 Nov 2024 09:49

Bavarian Nordic Announces Interim Results for the First Nine Months of 2024

Bavarian Nordic Announces Interim Results for the First Nine Months of 2024

GlobeNewswire • 15 Nov 2024 07:39

First Children Vaccinated in New Clinical Study Seeking to Expand the Indication for Bavarian Nordic’s Mpox Vaccine

First Children Vaccinated in New Clinical Study Seeking to Expand the Indication for Bavarian Nordic’s Mpox Vaccine

GlobeNewswire • 29 Oct 2024 07:30

Bavarian Nordic Upgrades its Financial Guidance for 2024

Bavarian Nordic Upgrades its Financial Guidance for 2024

GlobeNewswire • 26 Sep 2024 16:30

Bavarian Nordic Signs Agreement with UNICEF for 1 Million Mpox Vaccines

Bavarian Nordic Signs Agreement with UNICEF for 1 Million Mpox Vaccines

GlobeNewswire • 26 Sep 2024 16:30

Bavarian Nordic Awarded USD 63 Million from the U.S. Government for Production and Supply of Additional Smallpox/Mpox Vaccines

Bavarian Nordic Awarded USD 63 Million from the U.S.

GlobeNewswire • 24 Sep 2024 17:30

Bavarian Nordic Receives EMA Approval of Mpox Vaccine for Adolescents

Bavarian Nordic Receives EMA Approval of Mpox Vaccine for Adolescents

GlobeNewswire • 19 Sep 2024 15:45

Gavi Signs Agreement with Bavarian Nordic to Rapidly Secure 500,000 Doses of Mpox Vaccines for Africa

Gavi Signs Agreement with Bavarian Nordic to Rapidly Secure 500,000 Doses of Mpox Vaccines for Africa

GlobeNewswire • 18 Sep 2024 10:45

Canada's Only Single-Dose Cholera Vaccine Available Nationwide

Canada's Only Single-Dose Cholera Vaccine Available Nationwide

GlobeNewswire • 16 Sep 2024 14:00

Bavarian Nordic Receives WHO Prequalification for Mpox Vaccine

Bavarian Nordic Receives WHO Prequalification for Mpox Vaccine

GlobeNewswire • 13 Sep 2024 11:57

Bavarian Nordic Provides Update on the Mpox Vaccine Supply Situation

Bavarian Nordic Provides Update on the Mpox Vaccine Supply Situation

GlobeNewswire • 12 Sep 2024 10:54

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/com...

GlobeNewswire • 06 Sep 2024 18:00

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/com...

GlobeNewswire • 05 Sep 2024 18:00

First Doses of Bavarian Nordic’s Mpox Vaccine Now Arriving in the Democratic Republic of Congo

First Doses of Bavarian Nordic’s Mpox Vaccine Now Arriving in the Democratic Republic of Congo

GlobeNewswire • 05 Sep 2024 13:19

Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise

Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise

GlobeNewswire • 05 Sep 2024 10:22

Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Singapore

Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Singapore

GlobeNewswire • 27 Aug 2024 08:00

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/com...

GlobeNewswire • 23 Aug 2024 18:00

Bavarian Nordic Announces First Half 2024 Results

Bavarian Nordic Announces First Half 2024 Results

GlobeNewswire • 22 Aug 2024 07:45

Bavarian Nordic Receives 440,000 Dose Contract to Supply Smallpox and Mpox Vaccines for Undisclosed European Country

Bavarian Nordic Receives 440,000 Dose Contract to Supply Smallpox and Mpox Vaccines for Undisclosed European Country

GlobeNewswire • 21 Aug 2024 19:30

Bavarian Nordic Provides Statement on Mpox Vaccine Supply and Collaboration with African and Global Stakeholders

Bavarian Nordic Provides Statement on Mpox Vaccine Supply and Collaboration with African and Global Stakeholders

GlobeNewswire • 17 Aug 2024 13:26

Bavarian Nordic Submits Data to EMA to Extend Mpox/Smallpox Vaccine Approval to Adolescents

Bavarian Nordic Submits Data to EMA to Extend Mpox/Smallpox Vaccine Approval to Adolescents

GlobeNewswire • 16 Aug 2024 07:30

Bavarian Nordic Receives Order from HERA and Announces Significant Donation of Vaccines in Response to the Mpox Outbreak in Africa

Bavarian Nordic Receives Order from HERA and Announces Significant Donation of Vaccines in Response to the Mpox Outbreak in Africa

GlobeNewswire • 13 Aug 2024 22:15

Bavarian Nordic Announces FDA Acceptance and Priority Review of the BLA for its Chikungunya Vaccine

Bavarian Nordic Announces FDA Acceptance and Priority Review of the BLA for its Chikungunya Vaccine

GlobeNewswire • 13 Aug 2024 19:44

Bavarian Nordic Receives USD 156.8 Million from the U.S. Government for Additional Smallpox/Mpox Vaccine Production

Bavarian Nordic Receives USD 156.8 Million from the U.

GlobeNewswire • 08 Aug 2024 06:49

Bavarian Nordic Receives Positive CHMP Opinion for Including Mpox Real-world Effectiveness Data in European Marketing Authorization for Smallpox and Mpox Vaccine

Bavarian Nordic Receives Positive CHMP Opinion for Including Mpox Real-world Effectiveness Data in European Marketing Authorization for Smal...

GlobeNewswire • 26 Jul 2024 08:00

Bavarian Nordic Receives EMA Filing Acceptance and Validation of the MAA for its Chikungunya Vaccine

Bavarian Nordic Receives EMA Filing Acceptance and Validation of the MAA for its Chikungunya Vaccine

GlobeNewswire • 18 Jul 2024 09:15

Bavarian Nordic Converts Existing Credit Facility into Sustainability-linked Loan

Bavarian Nordic Converts Existing Credit Facility into Sustainability-linked Loan

GlobeNewswire • 01 Jul 2024 08:30

Bavarian Nordic Joins Global Efforts to Fight Mpox Outbreak in Africa

Bavarian Nordic Joins Global Efforts to Fight Mpox Outbreak in Africa

GlobeNewswire • 28 Jun 2024 16:27

Bavarian Nordic Submits Marketing Authorization Application for its Chikungunya Vaccine Candidate to EMA

Bavarian Nordic Submits Marketing Authorization Application for its Chikungunya Vaccine Candidate to EMA

GlobeNewswire • 26 Jun 2024 10:25

Bavarian Nordic Completes BLA Submission to U.S. FDA for its Chikungunya Vaccine Candidate

Bavarian Nordic Completes BLA Submission to U.S. FDA for its Chikungunya Vaccine Candidate

GlobeNewswire • 17 Jun 2024 16:21

Bavarian Nordic Submits Supplemental BLA Seeking U.S. FDA Approval of Freeze-Dried Formulation of Smallpox and Mpox Vaccine

Bavarian Nordic Submits Supplemental BLA Seeking U.

GlobeNewswire • 31 May 2024 16:33

Bavarian Nordic and CEPI Partners to Advance Mpox Vaccination in Africa

Bavarian Nordic and CEPI Partners to Advance Mpox Vaccination in Africa

GlobeNewswire • 30 May 2024 13:30

Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise

Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise

GlobeNewswire • 22 May 2024 10:07

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program

GlobeNewswire • 21 May 2024 23:25

EVP and Chief Medical Officer Laurence de Moerlooze Will Be Leaving Bavarian Nordic

EVP and Chief Medical Officer Laurence de Moerlooze Will Be Leaving Bavarian Nordic

GlobeNewswire • 21 May 2024 14:00

Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations

Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations

GlobeNewswire • 08 May 2024 07:48

Bavarian Nordic Announces Interim Results for the First Three Months of 2024

Bavarian Nordic Announces Interim Results for the First Three Months of 2024

GlobeNewswire • 08 May 2024 07:37

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/com...

GlobeNewswire • 07 May 2024 21:00

Bavarian Nordic Receives 65 mEUR Contract to Supply Smallpox Vaccines for EU Strategic Reserve

Bavarian Nordic Receives 65 mEUR Contract to Supply Smallpox Vaccines for EU Strategic Reserve

GlobeNewswire • 29 Apr 2024 21:30

Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine Candidate

Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine Candidate

GlobeNewswire • 29 Apr 2024 15:03

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/com...

GlobeNewswire • 22 Apr 2024 18:00

Resolutions of the Annual General Meeting 2024 of Bavarian Nordic A/S

Resolutions of the Annual General Meeting 2024 of Bavarian Nordic A/S

GlobeNewswire • 16 Apr 2024 18:20

Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.

Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.

GlobeNewswire • 02 Apr 2024 08:00

Bavarian Nordic A/S – Notice Convening Annual General Meeting

Bavarian Nordic A/S – Notice Convening Annual General Meeting

GlobeNewswire • 21 Mar 2024 12:00

Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Switzerland

Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Switzerland

GlobeNewswire • 13 Mar 2024 13:29

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/com...

GlobeNewswire • 12 Mar 2024 17:30

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/com...

GlobeNewswire • 06 Mar 2024 07:50

Bavarian Nordic Publishes Annual Report 2023

Bavarian Nordic Publishes Annual Report 2023

GlobeNewswire • 06 Mar 2024 07:38

Bavarian Nordic’s Chikungunya Vaccine Candidate Granted Accelerated Assessment by European Medicines Agency

Bavarian Nordic’s Chikungunya Vaccine Candidate Granted Accelerated Assessment by European Medicines Agency

GlobeNewswire • 23 Feb 2024 07:35

Bavarian Nordic delivered record financial results in 2023

Bavarian Nordic delivered record financial results in 2023

GlobeNewswire • 21 Feb 2024 08:13

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/com...

GlobeNewswire • 13 Dec 2023 22:42

New Incentive Program Established for Members of Executive Management and Selected Employees in Bavarian Nordic

New Incentive Program Established for Members of Executive Management and Selected Employees in Bavarian Nordic

GlobeNewswire • 13 Dec 2023 22:33

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/com...

GlobeNewswire • 30 Nov 2023 21:00

Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise

Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise

GlobeNewswire • 30 Nov 2023 10:47

Bavarian Nordic to hold Capital Markets Days in February 2024

Bavarian Nordic to hold Capital Markets Days in February 2024

GlobeNewswire • 22 Nov 2023 18:00

Bavarian Nordic Announces Interim Results for the First Nine Months of 2023

Bavarian Nordic Announces Interim Results for the First Nine Months of 2023

GlobeNewswire • 16 Nov 2023 07:37

Bavarian Nordic’s Mpox Vaccine Receives Recommendation from U.S. CDC Advisory Committee for Routine Use in Adults at Risk

Bavarian Nordic’s Mpox Vaccine Receives Recommendation from U.

GlobeNewswire • 25 Oct 2023 20:03

Bavarian Nordic Awarded Another Contract to Supply Smallpox Vaccines for EU Strategic Reserve

Bavarian Nordic Awarded Another Contract to Supply Smallpox Vaccines for EU Strategic Reserve

GlobeNewswire • 13 Sep 2023 11:33

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/com...

GlobeNewswire • 04 Sep 2023 14:06

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/com...

GlobeNewswire • 01 Sep 2023 13:09

Bavarian Nordic Provides Update on COVID-19 Booster Vaccine Program

Bavarian Nordic Provides Update on COVID-19 Booster Vaccine Program

GlobeNewswire • 31 Aug 2023 17:08

Bavarian Nordic Announces First Half 2023 Results

Bavarian Nordic Announces First Half 2023 Results

GlobeNewswire • 23 Aug 2023 07:35

Bavarian Nordic Reports Positive Phase 3 Topline Results for Chikungunya Virus Vaccine in Adults and Adolescents

Bavarian Nordic Reports Positive Phase 3 Topline Results for Chikungunya Virus Vaccine in Adults and Adolescents

GlobeNewswire • 06 Aug 2023 21:54

Bavarian Nordic Receives USD 120 Million Contract for the Manufacturing of Smallpox and Mpox Vaccine from the U.S. Government

Bavarian Nordic Receives USD 120 Million Contract for the Manufacturing of Smallpox and Mpox Vaccine from the U.

GlobeNewswire • 03 Aug 2023 07:28

Bavarian Nordic Provides Update on RSV Vaccine Program

Bavarian Nordic Provides Update on RSV Vaccine Program

GlobeNewswire • 22 Jul 2023 18:42

Bavarian Nordic Reports Phase 3 Topline Results for its COVID-19 Booster Vaccine Candidate

Bavarian Nordic Reports Phase 3 Topline Results for its COVID-19 Booster Vaccine Candidate

GlobeNewswire • 27 Jun 2023 14:43

Bavarian Nordic to Supply Smallpox Vaccines for EU Strategic Reserve

Bavarian Nordic to Supply Smallpox Vaccines for EU Strategic Reserve

GlobeNewswire • 23 Jun 2023 13:47

Bavarian Nordic Reports Data from a Phase 3 Clinical Trial of its VLP-Based Chikungunya Virus Vaccine in Adults ≥65 Years of Age

Bavarian Nordic Reports Data from a Phase 3 Clinical Trial of its VLP-Based Chikungunya Virus Vaccine in Adults ≥65 Years of Age

GlobeNewswire • 20 Jun 2023 08:39

Bavarian Nordic Reports 12-Month Durability Data from a Phase 2 Clinical Trial of its COVID-19 Vaccine Candidate

Bavarian Nordic Reports 12-Month Durability Data from a Phase 2 Clinical Trial of its COVID-19 Vaccine Candidate

GlobeNewswire • 16 Jun 2023 08:44

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/com...

GlobeNewswire • 12 Jun 2023 18:00

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/com...

GlobeNewswire • 23 May 2023 18:00

Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise

Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise

GlobeNewswire • 23 May 2023 12:14

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program

GlobeNewswire • 17 May 2023 23:13

Bavarian Nordic Completes Acquisition of Travel Vaccine Portfolio from Emergent BioSolutions

Bavarian Nordic Completes Acquisition of Travel Vaccine Portfolio from Emergent BioSolutions

GlobeNewswire • 15 May 2023 13:36

Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations

Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations

GlobeNewswire • 09 May 2023 07:52

Bavarian Nordic Announces Interim Results for the First Three Months of 2023

Bavarian Nordic Announces Interim Results for the First Three Months of 2023

GlobeNewswire • 09 May 2023 07:38

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/com...

GlobeNewswire • 01 May 2023 17:30

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/com...

GlobeNewswire • 25 Apr 2023 20:00

Bavarian Nordic Completes Case Accrual for RSV Phase 3 Clinical Trial

Bavarian Nordic Completes Case Accrual for RSV Phase 3 Clinical Trial

GlobeNewswire • 11 Apr 2023 13:16